首页|STEMI患者外周血单个核细胞中MAPK通路与炎症反应及PCI后无复流的关系

STEMI患者外周血单个核细胞中MAPK通路与炎症反应及PCI后无复流的关系

扫码查看
目的 研究ST段抬高型心肌梗死(STEMI)患者外周血单个核细胞(PBMCs)中丝裂原活化蛋白激酶(MAPK)通路与炎症反应及经皮冠状动脉介入术(PCI)后无复流的关系.方法 选取郑州市第七人民医院2021年2月至2022年10月进行PCI治疗的STEMI患者和同期进行体检的健康志愿者,分别作为STEMI组(n=92)和对照组(n=100).采用荧光定量PCR法检测PBMCs中p38MAPK、JNK的表达水平,根据中位数将STEMI组患者分为p38MAPK、JNK高表达和低表达.检测STEMI患者血清ICAM-1、TNF-α、IL-6含量,评估STEMI患者心肌损伤程度及无复流情况.结果 STEMI组患者PBMCs中p38MAPK、JNK的表达水平高于对照组,差异有统计学意义(t=5.386、5.126,P<0.05);STEMI组中p38MAPK、JNK高表达患者的CK-MB峰值、cTnT峰值及ICAM-1、TNF-α、IL-6含量均高于p38MAPK、JNK低表达患者,差异有统计学意义(t=7.143、4.999、9.528、6.805、6.890、6.226、8.132、7.807、7.162、7.588,P<0.05);STEMI组中无复流患者PBMCs中p38MAPK、JNK的表达水平高于血流正常患者,差异有统计学意义(t=5.208、4.240,P<0.05);经ROC曲线分析,PBMCs中p38MAPK、JNK的表达水平对STEMI患者PCI后无复流具有预测价值(P<0.05).结论 STEMI患者MAPK通路中p38MAPK、JNK的高表达与炎症反应激活、PCI后无复流有关.
Relationship between MAPK pathway in peripheral blood mononuclear cells and inflammatory response,no reflow after PCI in patients with STEMI
Objective To investigate the relationship between mitogen-activated protein kinase (MAPK)pathway in peripheral blood mononuclear cells(PBMCs)and inflammatory response,no reflow af-ter percutaneous coronary intervention(PCI)in patients with STEMI. Methods STEMI patients who under-went PCI from February 2021 to October 2022 and healthy volunteers who underwent physical examinations during the same period were divided into the STEMI group(n=92)and the control group(n=100),respec-tively. The expression levels of p38MAPK and JNK in PBMCs were detected using fluorescence quantitative PCR. Based on the median,the patients in the STEMI group were divided into high expression and low expres-sion groups for p38MAPK and JNK. The levels of ICAM-1,TNF-α and IL-6 in serum were tested,and the degree of myocardial injury and no reflow in STEMI patients were evaluated. Result The expression levels of p38MAPK and JNK in PBMCs of the STEMI group were higher than those of the control group ,and the differ-ence was statistically significant(t=5.386,5.126,P<0.05). The peak values of CK-MB,cTnT and the con-tents of ICAM-1,TNF-αand IL-6 in the serum of patients with high expression of p38MAPK and JNK in the STEMI group were higher than those of patients with low expression of p38MAPK and JNK. The difference was statistically significant(t=7.143,4.999,9.528,6.805,6.890,6.226,8.132,7.807,7.162,7.588,P<0.05). The expression levels of p38MAPK and JNK in PBMCs of patients with no reflow in the STEMI group were higher than those of patients with normal blood flow. The difference was statistically significant (t=5.208,4.240,P<0.05). The ROC curve analysis showed that the expression levels of p38MAPK and JNK in PBMCs can predict no reflow in STEMI patients after PCI. Conclusion The overexpression of p38MAPK and JNK in the MAPK pathway of STEMI patients is associated with the activation of inflammatory response and the occurrence of no reflow after PCI.

ST segment elevation myocardial infarctionPercutaneous coronary interventionMitogen activated protein kinaseInflammatory responseNo reflow

马龙飞、韩新宇、陈昌、王俊涛、王地

展开 >

郑州市第七人民医院心内科,河南,郑州450000

ST段抬高型心肌梗死 经皮冠状动脉介入术 丝裂原活化蛋白激酶 炎症反应 无复流

河南省医学科技攻关计划

LHGJ20210745

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(3)
  • 15